-
UAB and Children’s of Alabama celebrate five-year anniversary of NICU Bookworms programAug 21, 2026This year, City of Birmingham Mayor Randall Woodfin joined employees at UAB and Children’s of Alabama to celebrate the five-year anniversary of the NICU Bookworms program and recognize all that has been accomplished since its establishment. -
-
-
UAB startup NuVasc is advancing precision medicine for brain arteriovenous malformationsAug 17, 2026UAB startup NuVasc is advancing precision medicine for brain arteriovenous malformations with a novel liquid biopsy that identifies genetic mutations driving AVMs, paving the way for targeted therapies and improved patient outcomes. -
Implications on cancer biology and treatment through the origin recognition complex uncovered by UAB researchersAug 12, 2026UAB researchers are investigating the origin recognition complex, a key component of DNA replication, to better understand how cancer develops and identify potential new targets for treatment. -
Why clinical trials matter: Revolutionary new kidney treatments show what UAB can deliver for Alabama patientsAug 11, 2026Within the past three years, four pivotal clinical trials co-led by UAB’s Dana Rizk, M.D., have completely changed the treatment landscape for IgA nephropathy. “Many of the patients who took part in the trials here had tried and failed many other treatments,” Rizk said. “To know that they now have these new drugs available to them is remarkable.” -
-
-
Transformational $5 million gift to advance UAB O’Neal Cancer Center Clinical Trials ProgramAug 04, 2026This landmark investment will strengthen the UAB O’Neal Cancer Center’s nationally recognized clinical trials program and expand access to innovative cancer therapies for patients across Alabama and the Southeast. -
-
-
Microbe exposure and T cells drive anti-carbohydrate antibody productionJul 31, 2026A study reveals that T cells help develop diverse anti-carbohydrate antibodies after early microbial exposure, offering new insights into immune defense, autoimmune disease, asthma and future therapeutic development. -
-
Startup advances novel oral Type 1 diabetes therapy to next phase of human testingJul 29, 2026UAB startup TIXiMED advances TIX100, a novel oral Type 1 diabetes therapy, into Phase 1b clinical testing. The TXNIP-targeting drug aims to protect insulin-producing beta cells and address disease progression beyond blood sugar management. -
-
-
-
-
UAB to help lead NIH-funded population genomic screening initiative to advance population genomic screening in primary careJul 15, 2026UAB will help lead an NIH-funded Population Genomic Screening Network initiative to integrate genomic screening into primary care, enabling earlier detection of inherited cancer, cardiovascular and other genetic risks to improve prevention, health outcomes and equitable care. -
-
-
-
-
UAB trial shows first-in-human immunotherapy that more than doubles progression-free survival in glioblastoma patientsJul 09, 2026UAB researchers report Phase 1 trial results showing a novel immunotherapy was well-tolerated and doubled the progression-free survival time in glioblastoma patients, offering new optimism for improving survival and quality of life. -
-
-
New funding fuels research inspired by grandmother’s pneumonia hospitalizationJul 08, 2026A UAB researcher received NIH funding to study whether a ketogenic diet can help preserve muscle mass, strength and physical function in older adults hospitalized with pneumonia, potentially improving recovery and independence after discharge. -
-
-
-
-
-
Researchers awarded $8M grant to study long-term impact of Type 2 diabetes treatment for pregnant patients and their childrenJun 25, 2026Insulin is typically the first line of treatment for pregnant patients with Type 2 diabetes. This funding allows researchers to evaluate whether insulin combined with metformin leads to better outcomes for the mother and child. -
$10 million gift launches statewide effort to expand access to care in rural AlabamaJun 24, 2026UAB launches GRIT with a $10 million gift from the Goodrich family to expand rural Alabama healthcare, training and retaining primary care physicians, strengthening clinics, and improving access, outcomes and long-term community health. -
Service meets science: Meet the first graduate of UAB’s Master of Science in AI in MedicineJun 24, 2026Stevan Fairburn became the first graduate of a degree program that did not even exist a few years earlier. A program built around the belief that the future of medicine will require clinicians who understand both people and technology, both compassion and innovation. -
-
-
-
-